Medical specialists from India tagged as investigators in clinical trials studying Hemophilia A

Total 10 results

Aby Abraham, DM
Seen in:
- Tamil Nadu, Vellore, Christian Medical College Vellore
- Tamil Nadu, Vellore, Christian Medical College Vellore Ranipet Campus
Trials:
- NCT05265767 (Sub-Investigator)
Conditions:
- Hemophilia A
Alok Srivastava, MD
Seen in:
- Tamil Nadu, Vellore, Christian Medical College Vellore
- Tamil Nadu, Vellore, Christian Medical College Vellore Ranipet Campus
Trials:
- NCT05265767 (Principal Investigator)
Conditions:
- Hemophilia A
Fulton D'souza, MD
Seen in:
- Bangalore, St. John's Medical College Hospital
Trials:
- NCT02479087 (Sub-Investigator)
Conditions:
- Hemophilia A
Neeraj Siddharthan, MD, DM, DNB
Seen in:
- Kerala, Ernakulam, Amrita Institute of Medical Science & Research Centre
Trials:
- NCT04985682 (Principal Investigator)
Conditions:
- Hemophilia A
Renu Saxena, MD
Seen in:
- New Delhi, All India Institute of Medical Sciences
Trials:
- NCT02479087 (Sub-Investigator)
Conditions:
- Hemophilia A
Ross Cecil Reuben, MD
Seen in:
- Bengaluru, St. John's Medical College
Trials:
- NCT04985682 (Principal Investigator)
Conditions:
- Hemophilia A
Savita Rangarajan, MD
Seen in:
- Mumbai, K J Somaiya Hospital & Research Centre
Trials:
- NCT04985682 (Principal Investigator)
Conditions:
- Hemophilia A
Sita Lakshmi, MD
Seen in:
- Bangalore, St. John's Medical College Hospital
Trials:
- NCT02479087 (Sub-Investigator)
Conditions:
- Hemophilia A
Sunil Devichand Lohade, MBBS, DCH, DNB
Seen in:
- Pune, Unique Children's Hospital Pvt. Ltd.
Trials:
- NCT04985682 (Principal Investigator)
Conditions:
- Hemophilia A
Vandana Sharma, MD
Seen in:
- New Delhi, All India Institute of Medical Sciences
Trials:
- NCT02479087 (Sub-Investigator)
Conditions:
- Hemophilia A

Clinical Trials on Hemophilia A

Christoph Königs
Roche Pharma AG; Chugai Pharma Germany GmbH

Recruiting

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab (NAVIGATE)

Severe Hemophilia A | Severe Hemophilia A With Inhibitor | Severe Hemophilia A Without Inhibitor

Germany
GWT-TUD GmbH
Hannover Medical School; Hoffmann-La Roche

Completed

Emicizumab in Acquired Hemophilia A

Hemophilia A, Acquired

Austria, Germany
Kathelijn Fischer
Radboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaborators

Recruiting

Pharmacokinetic-guided Dosing of Emicizumab (DosEmi)

Adolescent | Child | Hemophilia A With Inhibitor | Adult | Hemophilia A Without Inhibitor | Hemophilia A, Severe

Netherlands
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis (Beyond ABR)

Severe Hemophilia A | Moderate Hemophilia A

Brazil, Germany, Italy, Spain, United States, Turkey, United Kingdom, Tunisia, Canada, Hungary, Morocco, Serbia
Catalyst Biosciences

Completed

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Hemophilia A | Hemophilia B | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Hemophilia A Without Inhibitor | Hemophilia B Without Inhibitor

Bulgaria, Russian Federation
JW Pharmaceutical

Recruiting

The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII Inhibitors

Hemophilia A With Inhibitor | Hemophilia A Without Inhibitor

Korea, Republic of
Pfizer

Completed

Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe

Factor VIII Deficiency, Congenital | Hemophilia A, Congenital | Factor 8 Deficiency, Congenital | Autosomal Hemophilia A | Classic Hemophilia
BioMarin Pharmaceutical

Recruiting

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors (GENEr8-INH)

Hemophilia A With Inhibitor | Hemophilia A With Anti Factor VIII

United States, United Kingdom, Taiwan, Israel, Korea, Republic of, South Africa, Brazil, Italy, Germany
American Thrombosis and Hemostasis Network
Takeda; CSL Behring; Octapharma

Completed

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Hemophilia A | Hemophilia B | Hemophilia | Hemophilia A With Inhibitor | Haemophilia | Hemophilia B With Inhibitor | Haemophilia A Without Inhibitor | Haemophilia B Without Inhibitor

United States
Bayer

Completed

A Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe Hemophilia

Hemophilia A; Hemophilia B

Israel

Medical specialists from India tagged as investigators in clinical trials studying Hemophilia A

Clinical Trials on Hemophilia A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations